Influenza Vaccination Coverage in Children: How Has COVID-19 Influenced It? A Review of Five Seasons (2018-2023) in Central Catalonia, Spain


Por: Burgaya-Subirana S, Balaguer-Gargallo M, Miró Catalina Q, Sola L and Ruiz-Comellas A

Publicada: 1 ago 2024 Ahead of Print: 18 ago 2024
Resumen:
Influenza vaccination is the main method of preventing influenza. Vaccination is recommended for certain individuals with diseases that could cause complications in the case of flu infection. The objective of this retrospective observational study was to examine influenza vaccination coverage in patients with risk factors, to describe the characteristics of those vaccinated and to study the influence of COVID-19. The study population was children under 14 years old with risk factors between 2018/19 and 2022/23 in Central Catalonia, sourced through the electronic database of the Catalan Institute of Health. The association of influenza vaccination data with sociodemographic data and risk factors was performed by bivariate and multivariate analysis. A total of 13,137 children were studied. Of those, 4623 had received the influenza vaccine in at least one season. The average influenza vaccination rate was 28.8%. The statistically significant factors associated with vaccination were age and having certain risk factors: asthma, diabetes, haemoglobinopathies and clotting disorders. In all seasons, the immigrant population was vaccinated more than the native population p < 0.05, except for the COVID-19 season (2020/21), where no differences were observed. Of those vaccinated, 7.1% had been vaccinated for 5 consecutive years. Influenza vaccination coverage in the paediatric age group was low. Vaccination promotion measures must be implemented. COVID-19 meant an increase in vaccination of the native population to the same level as that of the immigrant population.

Filiaciones:
Burgaya-Subirana S:
 Pediatrics Department, EAP Manlleu, Institut Català de la Salut, Gerència d'Atenció Primària i a la Comunitat de la Catalunya Central, C/Castellot, 17, 08560 Manlleu, Barcelona, Spain

 Faculty of Medicine, Universitat de Vic-Universitat Central de Catalunya, Cta/Roda, 70, 08500 Vic, Barcelona, Spain

Balaguer-Gargallo M:
 Faculty of Medicine, Universitat de Vic-Universitat Central de Catalunya, Cta/Roda, 70, 08500 Vic, Barcelona, Spain

 Pediatric Intensive Care Unit, Hospital Sant Joan de Déu Barcelona, Passeig Sant Joan de Déu, 2, 08950 Esplugues de Llobregat, Barcelona, Spain

Miró Catalina Q:
 Research Department, Institut Català de la Salut, Gerència d'Atenció Primària i a la Comunitat de la Catalunya Central, C/Pica d'Estats, 13-15, 08272 Sant Fruitós de Bages, Barcelona, Spain

Sola L:
 Research Department, Institut Català de la Salut, Gerència d'Atenció Primària i a la Comunitat de la Catalunya Central, C/Pica d'Estats, 13-15, 08272 Sant Fruitós de Bages, Barcelona, Spain

Ruiz-Comellas A:
 Faculty of Medicine, Universitat de Vic-Universitat Central de Catalunya, Cta/Roda, 70, 08500 Vic, Barcelona, Spain

 Research Department, Institut Català de la Salut, Gerència d'Atenció Primària i a la Comunitat de la Catalunya Central, C/Pica d'Estats, 13-15, 08272 Sant Fruitós de Bages, Barcelona, Spain

 Medicine Department, EAP Sant Joan de Vilatorrada, Institut Català de la Salut, Gerència d'Atenció Primària i a la Comunitat de la Catalunya Central, Avinguda del Torrent del Canigó, 0, 08250 Sant Joan de Vilatorrada, Catalonia, Spain
ISSN: 2076393X





Vaccines
Editorial
MDPI, MDPI AG, Grosspeteranlage 5, CH-4052 BASEL, SWITZERLAND, Suiza
Tipo de documento: Article
Volumen: 12 Número: 8
Páginas:
WOS Id: 001308570900001
ID de PubMed: 39204048
imagen Green Submitted, gold

MÉTRICAS